Association between factor v leiden gene mutation and systemic involvement in behcet's disease Behçet hastaliǧinda sistemik tutulum ve faktör v leiden gen mutasyonu arasindaki Ilişki


CEBECİ KAHRAMAN F., Topçu E., Onsun N., Su Ö.

Turkderm Deri Hastaliklari ve Frengi Arsivi, cilt.43, sa.1, ss.21-24, 2009 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 1
  • Basım Tarihi: 2009
  • Dergi Adı: Turkderm Deri Hastaliklari ve Frengi Arsivi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.21-24
  • Anahtar Kelimeler: Behcet's disease and factor v leiden gene mutation
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background and Design: Behcet's disease is a chronic, multisystem inflammatory disease of unknown origin characterized mainly by recurrent oral aphthous ulceration, genital ulceration, skin lesions and uveitis. Thrombophilic defects, such as factor V Leiden (FVL) gene mutation may play a role in the pathogenesis of thrombosis in Behcet's disease (BD). Recently, an association of FVL mutation with thrombosis and ocular involvement in BD has been reported. The object of this present study was to investigate an association between systemic involvement and the presence of the FVL gene mutation in BD patients. Material and Method: One-hundred six patients with BD and 70 healthy subjects were included in the study. FVL gene mutation was determined by polymerase chain reaction. Results: The FVL mutation was detected in 20.8% of the BD patients (22/106) compared with 8.5% of the control subjects (6/71). The difference was not statistically significant (p=0.027). Systemic involvement were observed in 45 (42.4%) patients. No statistically significant association was found between patients with systemic involvement (26.7%) and without systemic involvement (16.4%) with respect to FVL gene mutation (p=0.197). All of the patients and controls tested positive were heterozygous for the mutation. Conclusion: Further studies in larger patients series with systemic involvement are needed to determine the prevalence of this mutation in BD with systemic involvement.